Findings
What do systematic reviews say? 4,760 questions · 8,065 findings · 1,036 reviews
1,686 · 20.9% 675 · 8.4% 1,953 · 24.2% 2,048 · 25.4% 1,296 · 16.1% 407 · 5%
Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Measures of psychosocial factors · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Physical symptoms (physical) · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Sexual symptoms (sexual) · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Body image · female BRCA carriers post‐risk‐reducing surgery
1 finding from 1 review
Quality of life · adult women, 18 years of age or older, who tested positive for a pathogenic mutation in BRCA1 or BRCA2 and who had had risk‐reducing surgery
1 finding from 1 review
no estimate extracted
0 participants
Urologic symptom scores · men with benign prostatic hyperplasia
1 finding from 1 review
Quality of life · men with benign prostatic hyperplasia
1 finding from 1 review
Major adverse events · men with benign prostatic hyperplasia
It is very uncertain whether aquablation changes major adverse events compared with transurethral resection of the prostate (very low certainty).
1 finding from 1 review
Retreatment · men with benign prostatic hyperplasia
It is very uncertain whether aquablation changes retreatment compared with transurethral resection of the prostate (very low certainty).
1 finding from 1 review
Erectile function · men with benign prostatic hyperplasia
1 finding from 1 review
Ejaculatory function · men with benign prostatic hyperplasia
1 finding from 1 review
Intervention not reported Success of prosthetic rehabilitation (preference) (1 day) · adults over the age of 50 with a unilateral transfemoral amputation
1 finding from 1 review
Intervention not reported Adverse effects (1 day) · adults over the age of 50 with a unilateral transfemoral amputation
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
Urological symptom scores
1 finding from 1 review
Sexual adverse events
Naftopidil probably leads to lower sexual adverse events compared with silodosin (alpha‐blocker) (moderate certainty).
1 finding from 1 review
Urological symptom scores
1 finding from 1 review
Quality of life
1 finding from 1 review
Treatment withdrawal
1 finding from 1 review
Cardiovascular adverse events
1 finding from 1 review
Sexual adverse events
1 finding from 1 review
evidence gaps · evidencegaps.com
Not clinical guidance. Data from the Cochrane Library (Summary of Findings tables and full text), PubMed and Crossref, extracted by the Evidence Gaps pipeline. Related-question groupings and the gap map key are proposals pending human validation. A review that found no studies, or no review at all, is not proof that no research exists.